GENE ONLINE|News &
Opinion
Blog

ASCO 2024
ASCO Breakthrough 2024: Key Advances in the NSCLC Landscape with First-line Treatment Selpercatinib Trial Updates
2024-08-08
ASCO Breakthrough 2024: Radiation Alone Works as Well as Chemoradiation for Low-Risk Nasopharyngeal Cancer
2024-08-08
New Research Highlights Potential for Surgery-Free Management of Esophageal Cancer at ASCO Breakthrough 2024
2024-08-08
Merck Buys EyeBio for $3B and Shares Global Policy Perspectives During BIO in San Diego
2024-06-20
Johnson & Johnson’s Bispecific Antibodies for Atopic Dermatitis and Talks of Biotech Partnerships at BIO 2024
2024-06-20
Merck’s KEYNOTE-522 Success; BMS Licenses PRX019, Prothena Gets $80M
2024-06-19
ASCO 2024: Covering Skin Cancer, Bispecific Antibody Treatment, TIGIT-Targeted Drugs, Radiotherapy and More
2024-05-29
Major Cancer Research Publications at the 2024 American Society of Clinical Oncology Annual Meeting
2024-05-28
LATEST
Alliance for Clinical Trials in Oncology Highlights Research Initiatives on World Breast Cancer Research Day
2026-08-18
Great Science Is Only the First Step Toward U.S. Healthcare Success
2026-08-18
European Patent Office Grants Godavari Biorefineries Patent for Anti-Cancer Drug Formulation
2026-08-18
One in 20 Australian Women Now Receive Intravenous Iron Infusions
2026-08-18
UL Research Institutes Appoints Dr. Chao-Yang Wang to Lead Electrochemical Safety Research Institute
2026-08-17
SUNY Polytechnic Institute Receives $15,000 Grant to Develop Mechanical Lung Model
2026-08-17
MetaboAnalyst 6.0 Released for LC-MS2 Environmental Exposure and Dose-Response Analysis
2026-08-17
Scroll to Top